608. Ji X, et al. (2023) J Clin Oncol, 41: 1909. 609. Mohile SG, et al. (2016) Cancer, 122: 2459. 610. Poisson J, et al. (2021) J Cachexia Sarcopenia Muscle, 12: 1477. 611. Dunne RF, et al. (2019) J Geriatr Oncol, 10: 415. 612. Cruz-Jentoft AJ, et al. (2019) Age Ageing, 48: 16. 613. Fukuda Y, et al. (2016) Gastric Cancer, 19: 986. 614. Wang SL, et al. (2016) Ann Surg Oncol, 23: 556. 615. Tegels JJ, et al. (2015) J Surg Oncol, 112: 403. 616. Rees-Punia E, et al. (2023) JAMA Oncol, 9: 79. 617. Campbell KL, et al. (2022) JCO Oncol Pract, 18: e697. 618. Brown JC, et al. (2023) Br J Sports Med, 57: 965. 619. Joaquim A, et al. (2022) Front Oncol, 12: 955505. 620. Mavropalias G, et al. (2023) Breast Cancer, 30: 139. 621. Chen LH, et al. (2022) JAMA Netw Open, 5: e2242660. 622. Morice P, et al. (2012) Lancet, 379: 558. 623. Deshmukh AA, et al. (2018) JNCI Cancer Spectr, 2: pky022. 624. Schwedhelm C, et al. (2016) Nutr Rev, 74: 737. 625. Castro-Espin C, et al. (2022) Nutrients, 14. 626. Liu ZY, et al. (2022) J Transl Med, 20: 376. 627. Wang X, et al. (2023) JAMA Netw Open, 6: e2311966. 628. Young AL, et al. (2023) JAMA Oncol, 9: 981. 629. Bakitas M, et al. (2009) JAMA, 302: 741. 630. Zimmermann C, et al. (2014) Lancet, 383: 1721. 631. Temel JS, et al. (2010) N Engl J Med, 363: 733. 632. Bigi S, et al. (2023) Front Public Health, 11: 1092145. 633. Luo XF, et al. (2023) Front Oncol, 13: 1104447. 634. Gregoire C, et al. (2022) Curr Opin Oncol, 34: 270. 635. Koizumi T, et al. (2023) Cancer, 129: 2568. 636. Akechi T, et al. (2023) J Clin Oncol, 41: 1069. 637. Fu X, et al. (2022) Front Public Health, 10: 927370. 638. Lang-Rollin I, et al. (2018) Dialogues Clin Neurosci, 20: 13. 639. Dos Santos M, et al. (2020) Cancer, 126: 5328. 640. Lleras de Frutos M, et al. (2020) Psychooncology, 29: 1995. 641. Menger F, et al. (2021) Support Care Cancer, 29: 7013. 642. Gorin SS, et al. (2017) Ann Behav Med, 51: 532. 643. Edward JS, et al. (2023) JCO Oncol Pract, 19: e696. 644. Oluwole SF, et al. (2003) J Am Coll Surg, 196: 180. 645. Percac-Lima S, et al. (2016) JAMA Intern Med, 176: 930. 646. Ritvo PG, et al. (2015) Cancer Epidemiol Biomarkers Prev, 24: 506. 647. Percac-Lima S, et al. (2015) Cancer, 121: 1662. 648. Liang H, et al. (2020) Health Care Manage Rev, 45: 364. 649. Basch E, et al. (2023) J Clin Oncol, 41: 3724. 650. Friends of Cancer Research. Broadening the Definition of Tolerability in Cancer Clinical Trials to Better Measure the Patient Experience. Accessed: July 31, 2023. Available from: https://friendsofcancerresearch.org/wp-content/uploads/ Comparative-Tolerability-Whitepaper_FINAL.pdf. 651. Natori A, et al. (2023) J Clin Oncol, 41: 285. 652. Thanarajasingam G, et al. (2022) Lancet Haematol, 9: e374. 653. Temple-Oberle C, et al. (2023) JAMA Surg, 158: 693. 654. Graetz I, et al. (2023) Cancer Med, 12: 6190. 655. Villanueva-Bueno C, et al. (2022) Front Public Health, 10: 978783. 656. National Partnership for Women and Families. Paid leave could keep more than 6 million caregivers connected to the labor force by 2030. Accessed: June 30, 2023. Available from: https://www.nationalpartnership.org/ our-work/resources/economic-justice/paid-leave/paidleave-caregivers-connected-2030.pdf. 657. Hess LM, et al. (2021) BMC Health Serv Res, 21: 894. 658. Fenton A, et al. (2022) Support Care Cancer, 30: 9625. 659. Oakley-Girvan I, et al. (2023) PLOS Digit Health, 2: e0000173. 660. Ozluk P, et al. (2022) J Med Internet Res, 24: e28504. 661. Guessi Margarido M, et al. (2022) NPJ Digit Med, 5: 33. 662. Hu K, et al. (2023) JAMA Netw Open, 6: e2249560. 663. Williams CG, et al. (2022) Genome Med, 14: 68. 664. Tang F, et al. (2009) Nat Methods, 6: 377. 665. Fan L, et al. (2022) Cancer Res, 82: 2034. 666. Tian L, et al. (2022) Nat Biotechnol, 41: 773. 667. Peng Z, et al. (2022) J Transl Med, 20: 302. 668. Zhang Q, et al. (2022) Nat Commun, 13: 5983. 669. Kim H, et al. (2020) Nat Genet, 52: 891. 670. Luebeck J, et al. (2023) Nature, 616: 798. 671. Hung KL, et al. (2021) Nature, 600: 731. 672. Lange JT, et al. (2022) Nat Genet, 54: 1527. References AACR Cancer Progress Report 2023 179
RkJQdWJsaXNoZXIy NTkzMzk=